BioSpace News Archive

VerdePharmHealth today announced the signing of an exclusive national group purchasing agreement with Greene Street Pharmaceuticals that will utilize proprietary CBD-Cubed™ transdermal 24-hour delivery technology for multi-specialty patients.

Novant Health-GoHealth Urgent Care launched its video visit platform, providing patients as young as one year old with urgent care services from the comfort of their homes.

Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced that Gilles Gagnon, M.Sc., MBA, President and CEO of Ceapro will present at the Virtual Investor Fireside Chat Series on Wednesday, June 17, 2020 at 10:00 AM ET.

Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it has entered into an underwriting agreement with Oppenheimer & Co. Inc. under which the underwriter agreed to purchase, on a firm commitment basis,

Renibus Therapeutics, Inc, a clinical-stage biotechnology company, is pleased to announce that data highlighting the translation of the mechanism of action of its clinical drug candidate RBT-1 from animals to humans was selected for scientific presentation at the ERA-EDTA Annual Congress. The poster titled “Oxidant-Induced Renal Preconditioning Biomarkers for AKI Prevention with RBT-1,” was presented by Richard Zager, MD, Professor of Medicine, Unive

Today Lexogen, the transcriptomics and next-generation sequencing company, launched the new TraPR Small RNA Isolation Kit. TraPR ( T rans- K ingdom, R apid, A ffordable P urification of R ISCs) is a breakthrough method that enables a gel free isolation of functional small RNAs (sRNAs) and allows for a cost-efficient, accurate, and highly r

St. Jude Children’s Research Hospital® announced details for the 2020 St. Jude JAM presented by Delta Dental of Tennessee and InnerWorkings.

Ceek Women’s Health, the women-led, groundbreaking medical device company and Lupin Pharmaceuticals Inc., the US sales and marketing subsidiary of Lupin Limited, announced an agreement to add the Nella women’s health products to Lupin’s promotional offering in the United States.

Spring 2020 Release Delivers New Integrations, an Updated UI and Standards Compliance Features to Optimize Efficiency and Capture More Revenue

Patent protects foundational intellectual property and pioneering work on Pandion’s therapeutic autoimmune regulatory protein (TALON) drug design platform CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Pandion Therapeutics , a clinical-stage, privately held biotechnology company developing modular protein therapeutics for autoimmune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,676,516 with claims covering b